Provention Bio, Inc.

PRVBNASDAQHealthcare

$24.98

+$0.00(+0.00%)

Market Cap$2.4B

P/E Ratio—

52W High$25.0

52W Low$3.185

Avg Volume2.8M

Open$24.99

Beta2.46

Insider Trades Ownership Employees

Provention Bio, Inc. (PRVB) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · PRVB · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Provention Bio, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

PRVB insider buying and selling by quarter

PRVB insider selling · PRVB insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

42.1M21.1M0

2021 Q3

2021 Q4

2022 Q1

2022 Q2

2022 Q3

2022 Q4

2023 Q1

2023 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Recent insider transactions

PRVB executive sell shares · PRVB board member insider trading · PRVB insider trading SEC filing

Showing 30 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Apr 27, 2023	Sessa Capital (Master), L.P. 10 percent owner	Other	15,567,497	$0.00	$2K	0	Form 4
Apr 27, 2023	Pisano Wayne Director	Other	7,500	$25.00	$188K	0	Form 4
Apr 27, 2023	Palmer Ashleigh Director and CEO	Other	2,570,050	$25.00	$64.25M⚡	0	Form 4
Apr 27, 2023	CATLIN AVERY W Director	Other	10,000	$25.00	$250K	0	Form 4
Apr 27, 2023	Ramos Eleanor Chief Medical Officer	Other	70,000	$25.00	$1.75M⚡	0	Form 4
Apr 27, 2023	Leon Francisco Chief Scientific Officer	Other	1,000,000	$25.00	$25.00M⚡	0	Form 4
Apr 20, 2023	Sessa Capital (Master), L.P. 10 percent owner	Gift	202,314	—	—	224,617	Form 4
Apr 21, 2023	Sessa Capital (Master), L.P. 10 percent owner	Gift	224,617	—	—	0	Form 4
Apr 14, 2023	Sessa Capital (Master), L.P. 10 percent owner	Other	8,879,023	$6.00	$53.27M⚡	17,758,046	Form 4
Apr 14, 2023	Sessa Capital (Master), L.P. 10 percent owner	Sale	2,190,549	$24.32	$53.27M⚡	15,567,497	Form 4
Apr 13, 2023	Leon Francisco Chief Scientific Officer	Gift	1,500,000	—	—	73,000	Form 4
Apr 13, 2023	Leon Francisco Chief Scientific Officer	Gift	1,500,000	—	—	73,000	Form 4
Apr 13, 2023	CATLIN AVERY W Director	Gift	10,000	—	—	10,000	Form 4
Apr 13, 2023	CATLIN AVERY W Director	Gift	10,000	—	—	10,000	Form 4
Mar 31, 2023	Sessa Capital (Master), L.P. 10 percent owner	Other	3,000,000	—	—	8,879,023	Form 4
Apr 4, 2023	Sessa Capital (Master), L.P. 10 percent owner	Gift	218,651	—	—	426,931	Form 4
Feb 10, 2023	Leon Francisco Chief Scientific Officer	Option	50,000	$2.50	$125K	1,623,000	Form 4
Feb 13, 2023	Leon Francisco Chief Scientific Officer	Option	25,985	$2.50	$65K	1,598,985	Form 4
Feb 10, 2023	Leon Francisco Chief Scientific Officer	Sale	50,000	$10.11	$506K	1,573,000	Form 4
Feb 13, 2023	Leon Francisco Chief Scientific Officer	Sale	25,985	$10.04	$261K	1,573,000	Form 4
Feb 10, 2023	Hoitt Jason Chief Commercial Officer	Sale	4,500	$10.00	$45K	0	Form 4
Feb 10, 2023	Palmer Ashleigh Director and CEO	Option	50,000	$2.50	$125K	2,620,050	Form 4
Feb 13, 2023	Palmer Ashleigh Director and CEO	Option	25,835	$2.50	$65K	2,595,885	Form 4
Feb 10, 2023	Palmer Ashleigh Director and CEO	Sale	50,000	$10.11	$506K	2,570,050	Form 4
Feb 13, 2023	Palmer Ashleigh Director and CEO	Sale	25,835	$10.04	$259K	2,570,050	Form 4

Sessa Capital (Master), L.P.

10 percent owner

Other

Date

Apr 27

15,567,497

Price

$0.00

Value

$2K

View Form 4 on SEC.gov

Pisano Wayne

Director

Other

Date

Apr 27

7,500

Price

$25.00

Value

$188K

View Form 4 on SEC.gov

Palmer Ashleigh

Director and CEO

Other

Date

Apr 27

2,570,050

Price

$25.00

Value

$64.25M ⚡

View Form 4 on SEC.gov

CATLIN AVERY W

Director

Other

Date

Apr 27

10,000

Price

$25.00

Value

$250K

View Form 4 on SEC.gov

Ramos Eleanor

Chief Medical Officer

Other

Date

Apr 27

70,000

Price

$25.00

Value

$1.75M ⚡

View Form 4 on SEC.gov

Leon Francisco

Chief Scientific Officer

Other

Date

Apr 27

1,000,000

Price

$25.00

Value

$25.00M ⚡

View Form 4 on SEC.gov

Sessa Capital (Master), L.P.

10 percent owner

Gift

Date

Apr 20

202,314

Price

—

Value

—

View Form 4 on SEC.gov

Sessa Capital (Master), L.P.

10 percent owner

Gift

Date

Apr 21

224,617

Price

—

Value

—

View Form 4 on SEC.gov

Sessa Capital (Master), L.P.

10 percent owner

Other

Date

Apr 14

8,879,023

Price

$6.00

Value

$53.27M ⚡

View Form 4 on SEC.gov

Sessa Capital (Master), L.P.

10 percent owner

Sale

Date

Apr 14

2,190,549

Price

$24.32

Value

$53.27M ⚡

View Form 4 on SEC.gov

Leon Francisco

Chief Scientific Officer

Gift

Date

Apr 13

1,500,000

Price

—

Value

—

View Form 4 on SEC.gov

Leon Francisco

Chief Scientific Officer

Gift

Date

Apr 13

1,500,000

Price

—

Value

—

View Form 4 on SEC.gov

CATLIN AVERY W

Director

Gift

Date

Apr 13

10,000

Price

—

Value

—

View Form 4 on SEC.gov

CATLIN AVERY W

Director

Gift

Date

Apr 13

10,000

Price

—

Value

—

View Form 4 on SEC.gov

Sessa Capital (Master), L.P.

10 percent owner

Other

Date

Mar 31

3,000,000

Price

—

Value

—

View Form 4 on SEC.gov

Sessa Capital (Master), L.P.

10 percent owner

Gift

Date

Apr 4

218,651

Price

—

Value

—

View Form 4 on SEC.gov

Leon Francisco

Chief Scientific Officer

Option

Date

Feb 10

50,000

Price

$2.50

Value

$125K

View Form 4 on SEC.gov

Leon Francisco

Chief Scientific Officer

Option

Date

Feb 13

25,985

Price

$2.50

Value

$65K

View Form 4 on SEC.gov

Leon Francisco

Chief Scientific Officer

Sale

Date

Feb 10

50,000

Price

$10.11

Value

$506K

View Form 4 on SEC.gov

Leon Francisco

Chief Scientific Officer

Sale

Date

Feb 13

25,985

Price

$10.04

Value

$261K

View Form 4 on SEC.gov

Hoitt Jason

Chief Commercial Officer

Sale

Date

Feb 10

4,500

Price

$10.00

Value

$45K

View Form 4 on SEC.gov

Palmer Ashleigh

Director and CEO

Option

Date

Feb 10

50,000

Price

$2.50

Value

$125K

View Form 4 on SEC.gov

Palmer Ashleigh

Director and CEO

Option

Date

Feb 13

25,835

Price

$2.50

Value

$65K

View Form 4 on SEC.gov

Palmer Ashleigh

Director and CEO

Sale

Date

Feb 10

50,000

Price

$10.11

Value

$506K

View Form 4 on SEC.gov

Palmer Ashleigh

Director and CEO

Sale

Date

Feb 13

25,835

Price

$10.04

Value

$259K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About PRVB insider trading

PRVB insider trades

Provention Bio, Inc. (PRVB) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including PRVB. Over the past 12 months, 0 insiders have filed transactions with the SEC. PRVB insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Provention Bio, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

PRVB insider trading · 5 questions

The insiders of Provention Bio, Inc. (PRVB) include executives and directors such as PRVB, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

PRVB board member insider tradingwho are PRVB insidersPRVB insider rosterProvention Bio, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026